149 related articles for article (PubMed ID: 10467409)
61. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
Kovalev S; Marchenko N; Swendeman S; LaQuaglia M; Moll UM
Cell Growth Differ; 1998 Nov; 9(11):897-903. PubMed ID: 9831242
[TBL] [Abstract][Full Text] [Related]
62. Allele loss on chromosome 1p36 in epithelial ovarian cancers.
Alvarez AA; Lambers AR; Lancaster JM; Maxwell GL; Ali S; Gumbs C; Berchuck A; Futreal PA
Gynecol Oncol; 2001 Jul; 82(1):94-8. PubMed ID: 11426968
[TBL] [Abstract][Full Text] [Related]
63. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
Piaskowski S; Rieske P; Szybka M; Wozniak K; Bednarek A; Płuciennik E; Jaskolski D; Sikorska B; Liberski PP
Cancer Genet Cytogenet; 2005 Oct; 162(1):63-7. PubMed ID: 16157202
[TBL] [Abstract][Full Text] [Related]
64. The p73 gene is less involved in the development but involved in the progression of neuroblastoma.
Yang HW; Piao HY; Chen YZ; Takita J; Kobayashi M; Taniwaki M; Hashizume K; Hanada R; Yamamoto K; Taki T; Bessho F; Yanagisawa M; Hayashi Y
Int J Mol Med; 2000 Apr; 5(4):379-84. PubMed ID: 10719054
[TBL] [Abstract][Full Text] [Related]
65. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
[TBL] [Abstract][Full Text] [Related]
66. p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells.
Tomkova K; Belkhiri A; El-Rifai W; Zaika AI
Cancer Res; 2004 Sep; 64(18):6390-3. PubMed ID: 15374945
[TBL] [Abstract][Full Text] [Related]
67. p73 mutations are not detected in sporadic and hereditary breast cancer.
Schwartz DI; Lindor NM; Walsh-Vockley C; Roche PC; Mai M; Smith DI; Liu W; Couch FJ
Breast Cancer Res Treat; 1999 Nov; 58(1):25-9. PubMed ID: 10634515
[TBL] [Abstract][Full Text] [Related]
68. Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas.
Du CW; Kimijima I; Otake T; Abe R; Takenoshita S; Zhang GJ
Chin Med J (Engl); 2011 Aug; 124(15):2275-8. PubMed ID: 21933556
[TBL] [Abstract][Full Text] [Related]
69. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis.
Watson RH; Neville PJ; Roy WJ; Hitchcock A; Campbell IG
Oncogene; 1998 Jul; 17(2):207-12. PubMed ID: 9674705
[TBL] [Abstract][Full Text] [Related]
70. Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines.
Schittek B; Sauer B; Garbe C
Int J Cancer; 1999 Aug; 82(4):583-6. PubMed ID: 10404074
[TBL] [Abstract][Full Text] [Related]
71. Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens.
Hu JF; Ulaner GA; Oruganti H; Ivaturi RD; Balagura KA; Pham J; Vu TH; Hoffman AR
Biochim Biophys Acta; 2000 Apr; 1491(1-3):49-56. PubMed ID: 10760569
[TBL] [Abstract][Full Text] [Related]
72. Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.
Limpaiboon T; Tapdara S; Jearanaikoon P; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(27):4377-82. PubMed ID: 16865781
[TBL] [Abstract][Full Text] [Related]
73. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
74. Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Van Gele M; Kaghad M; Leonard JH; Van Roy N; Naeyaert JM; Geerts ML; Van Belle S; Cocquyt V; Bridge J; Sciot R; De Wolf-Peeters C; De Paepe A; Caput D; Speleman F
Br J Cancer; 2000 Feb; 82(4):823-6. PubMed ID: 10732753
[TBL] [Abstract][Full Text] [Related]
75. Tumor suppressor genes on the short arm of chromosome 1 in neuroblastoma.
Blatt J
Pediatr Hematol Oncol; 2001; 18(1):3-5. PubMed ID: 11205838
[No Abstract] [Full Text] [Related]
76. Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressiveness.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Sakon M; Matsuura N
Int J Mol Med; 2001 Jul; 8(1):67-71. PubMed ID: 11408952
[TBL] [Abstract][Full Text] [Related]
77. p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement.
Rödicker F; Pützer BM
Cancer Res; 2003 Jun; 63(11):2737-41. PubMed ID: 12782576
[TBL] [Abstract][Full Text] [Related]
78. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
[TBL] [Abstract][Full Text] [Related]
79. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
[TBL] [Abstract][Full Text] [Related]
80. Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors.
Neville PJ; Thomas N; Campbell IG
Int J Cancer; 2001 Feb; 91(3):345-9. PubMed ID: 11169958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
